Pregled bibliografske jedinice broj: 23319
Inhibition of acetylcholinesterase by three new pyridinium compounds and their effect on phosphonylation of the enzyme
Inhibition of acetylcholinesterase by three new pyridinium compounds and their effect on phosphonylation of the enzyme // Journal of Enzyme Inhibition, 14 (1999), 331-341 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 23319 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Inhibition of acetylcholinesterase by three new pyridinium compounds and their effect on phosphonylation of the enzyme
Autori
Škrinjarić-Špoljar, Mira ; Burger, Nicoletta ; Lovrić, Jasna
Izvornik
Journal of Enzyme Inhibition (8755-5093) 14
(1999);
331-341
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
mono-pyridinium compounds; acetylcholinesterase; reversible inhibition; Soman; VX; protection; reactivation
Sažetak
Three new compounds of the benzoyl-pyridinium type were prepared: 1-phenacyl-2-methylpyridinium chloride (1), 1-benzoylethyl-pyridinium chloride (2) and 1-benzoylethylpyridinium-4-aldoxime chloride (3) and assayed in vitro for their inhibitory effect on human blood acetylcholinesterase (EC 3.1.1.7, AChE). All the three compounds inhibited AChE reversibly; their binding affinity for the enzyme was compared with their protective effect (PI) in AChE phoshonylation by soman and VX. Compound 1 was found to bind to both enzyme binding sites and the evaluated enzyme/ligand dissociation constants for the catalytic (Ka) and the allosteric (Ki) site were 6.9 microM and 27 microM respectively. Compound 2 was bound to the catalytic site with Ka = 59 microM and compound 3 to the allosteric site with Ki = 328 microM. PI was evaluated from phosphonylation measured in the absence and in presence of the compounds applied in concentration corresponding to their Ka or Ki value, and was also calculated from theoretical equations deduced from the reversible inhibition of the enzyme. Compounds 1 and 3 protected the enzyme from phosphonylation by soman and VX, whereas no protection was observed in the presence of compound 2 under the same conditions. Irrespective of the binding sites to AChE PI for compounds 1 and 3 evaluated from phosphonylation agreed with PI calculated from reversible inhibition. Compound 3 was found to be a weak reactivator of methylphosphonylated AChE.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
00220104
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE